Jubilant Biosys Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is DEFERASIROX, with a corresponding US DMF Number 25888.
Remarkably, this DMF maintains an Active status since its submission on March 30, 2012, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of June 16, 2017, and payment made on May 25, 2017, indicating their dedication to facilitating drug approvals, Categorized as Type II